Single-chain variable fragment (scFv) of antibodies may have high affinity to antigens (e.g. EGFR) overexpressed in cancer cells and have been used to engineer oHSV envelope glycoproteins to target tumor (Jiang et al., 1998; Kuan et al., 2000). This evidence concerns the gene ERVW-1 and neoplasm.